Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells in Drug Discovery & Toxicity Screening 2018


Patient-Specific iPSC-derived Cardiomyocytes for Drug Development and Toxicity Testing

Ulrich Broeckel, Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin

Using iPSC-derived cell types holds the promise to revolutionize drug development and toxicity testing.  In particular, these cells provide a platform to incorporate both phenotypic variability and genetic diversity.  In the presentation, we will discuss the impact of phenotypic and genetic diversity on drug screening and toxicity testing.

Add to Calendar ▼2018-10-04 00:00:002018-10-05 00:00:00Europe/LondonStem Cells in Drug Discovery and Toxicity Screening 2018Stem Cells in Drug Discovery and Toxicity Screening 2018 in Coronado Island, CaliforniaCoronado Island,